Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial

Sanyal, 2010, Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis., N Engl J Med, 362, 1675, 10.1056/NEJMoa0907929 Belfort, 2006, A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis., N Engl J Med, 355, 2297, 10.1056/NEJMoa060326 Aithal, 2008, Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis., Gastroenterology, 135, 1176, 10.1053/j.gastro.2008.06.047 Ratziu, 2008, Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial., Gastroenterology, 135, 100, 10.1053/j.gastro.2008.03.078 Mannucci, 2010, Cardiac safety profile of rosiglitazone: a comprehensive meta-analysis of randomized clinical trials., Int J Cardiol, 143, 135, 10.1016/j.ijcard.2009.01.064 Hepgul, 2010, Preventive effect of pentoxifylline on acute radiation damage via antioxidant and anti-inflammatory pathways., Dig Dis Sci, 55, 617, 10.1007/s10620-009-0780-x Doherty, 1991, Pentoxifylline suppression of tumor necrosis factor gene transcription., Surgery, 110, 192 Duman, 2007, Effects of pentoxifylline on TNF-alpha production by peripheral blood mononuclear cells in patients with nonalcoholic steatohepatitis., Dig Dis Sci, 52, 2520, 10.1007/s10620-006-9723-y Koppe, 2004, Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet., J Hepatol, 41, 592, 10.1016/j.jhep.2004.06.030 Adams, 2004, A pilot trial of pentoxifylline in nonalcoholic steatohepatitis., Am J Gastroenterol, 99, 2365, 10.1111/j.1572-0241.2004.40064.x Satapathy, 2004, Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis., Am J Gastroenterol, 99, 1946, 10.1111/j.1572-0241.2004.40220.x Buranawati, 2007, Pentoxifylline for Treatment of Nonalcoholic Fatty Liver Disease (NA-FLD): A Randomized, Placebo-Controlled Study., Thai J Gastroenterol, 8, 57 Lee, 2008, A randomized controlled pilot study of Pentoxifylline in patients with non-alcoholic steatohepatitis (NASH)., Hepatol Int, 2, 196, 10.1007/s12072-008-9058-1 Ozawa, 2005, The endoplasmic reticulum chaperone improves insulin resistance in type 2 diabetes., Diabetes, 54, 657, 10.2337/diabetes.54.3.657 Ozcan, 2004, Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes., Science, 306, 457, 10.1126/science.1103160 Ozcan, 2006, Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes., Science, 313, 1137, 10.1126/science.1128294 Puri, 2008, Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease., Gastroenterology, 134, 568, 10.1053/j.gastro.2007.10.039 Xue, 2005, Tumor necrosis factor alpha (TNFalpha) induces the unfolded protein response (UPR) in a reactive oxygen species (ROS)-dependent fashion, and the UPR counteracts ROS accumulation by TNFalpha., J Biol Chem, 280, 33917, 10.1074/jbc.M505818200 Brunt, 1999, Nonalcoholic steatohepatitis (NASH): further expansion of this clinical entity?, Liver, 19, 263, 10.1111/j.1478-3231.1999.tb00047.x Kleiner, 2005, Design and validation of a histological scoring system for nonalcoholic fatty liver disease., Hepatology, 41, 1313, 10.1002/hep.20701 Prati, 2002, Updated definitions of healthy ranges for serum alanine aminotransferase levels., Ann Intern Med, 137, 1, 10.7326/0003-4819-137-1-200207020-00006 Kim, 2004, Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study., BMJ, 328, 983, 10.1136/bmj.38050.593634.63 Burra, 1992, Severity of alcoholic liver disease and markers of thyroid and steroid status., Postgrad Med J, 68, 804, 10.1136/pgmj.68.804.804 Brunt, 1999, Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions., Am J Gastroenterol, 94, 2467, 10.1111/j.1572-0241.1999.01377.x Akriviadis, 2000, Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial., Gastroenterology, 119, 1637, 10.1053/gast.2000.20189 Groesdonk, 2009, Urodilatin and pentoxifylline prevent the early onset of Escherichia coli-Induced acute renal failure in a model of isolated perfused rat kidney., Kidney Blood Press Res, 32, 81, 10.1159/000209378 Perkins, 2009, Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial., Am J Kidney Dis, 53, 606, 10.1053/j.ajkd.2008.11.026